Century Therapeutics (IPSC) Amortization - Deferred Charges (2020 - 2023)
Century Therapeutics (IPSC) reported Amortization - Deferred Charges of $38000.0 for Q2 2023, down 50.0% year-over-year from $76000.0 in Q2 2022, and down 32.14% quarter-over-quarter from $56000.0 in Q1 2023.
Century Therapeutics (IPSC) Amortization - Deferred Charges (2020 - 2023) Analysis & Trends
Century Therapeutics (IPSC) has 4 years of Amortization - Deferred Charges data on file, last reported at $38000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortization - Deferred Charges (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Century Therapeutics | 444.99 Mn | 444.99 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 38,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 56,000.00 |
| Mar 31, 2023 | 56,000.00 |
| Sep 30, 2022 | 77,000.00 |
| Sep 30, 2022 | 77,000.00 |
| Jun 30, 2022 | 76,000.00 |
| Jun 30, 2022 | 76,000.00 |
| Mar 31, 2022 | 76,000.00 |
| Mar 31, 2022 | 76,000.00 |
| Sep 30, 2021 | 77,000.00 |
| Sep 30, 2021 | 77,000.00 |
| Jun 30, 2021 | 76,000.00 |
| Jun 30, 2021 | 76,000.00 |
| Sep 30, 2020 | 14,000.00 |
| Sep 30, 2020 | 14,000.00 |